Navigation Links
SynteractHCR Addressing Successful Ways to Approach Sponsor and CRO Collaboration at May Pharmaceutical Events in US and Europe
Date:5/2/2013

SAN DIEGO, May 2, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global contract research organization (CRO), will attend and present at two conferences in May, Outsourcing in Clinical Trials Southeast and Outsourcing in Clinical Trials Europe. Speakers Barbara Ruby and Dr. Sonja Weiser will address the relationship between sponsors and outsourced clinical research organizations and how their collaboration aids in the success of trials.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Outsourcing in Clinical Trials Southeast will take place in Raleigh-Durham, NC from May 7-8, 2013. SynteractHCR will exhibit at booth #22. Barbara Ruby , associate project director, will present "CRO/Sponsor Successful Collaboration: How to Effectively Work Together" at 2:00 p.m. EDT on May 7th. Ms. Ruby has more than 20 years of experience in clinical research including multiple roles as a study coordinator, sub-investigator, monitor and project manager at both CROs and biotech companies. Her presentation will include how to establish a clinical trial agreement that is clear and comprehensive, how to create team transparency from the outset, and how to manage the unexpected and establish accountability.

The third annual Outsourcing in Clinical Trials Europe will take place in Zurich, Switzerland from May 14-15, 2013. SynteractHCR will exhibit at booth #33. Dr. Sonja Weiser ,Regional Director, Nordic & East, will present "Applying Result-driven Techniques to Successfully Transition (and Save) a Failing Study" at 4:00 p.m. CET on May 14th. The presentation will include how to determine when a service provider is not performing and identify when a change in service provider is needed, how to select a new CRO, and how to facilitate a smooth transition that keeps the study on track. Dr. Weiser has more than 13 years of experience in the field of clinical research in pharma and biotech, as well as six years experience in an international CRO environment.

In March, 2013 SynteractHCR was formed from the merger of Synteract and Harrison Clinical Research (HCR), and operates from 16 locations worldwide to support large, later phase programs. To set up an appointment, contact Matt Smith , SVP sales and marketing at (760) 268-8200.

About SynteractHCR (www.synteracthcr.com)

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.

CONTACT:
Rachel Hutman
Rachel@clearpointagency.com
760-230-2424

 


'/>"/>
SOURCE SynteractHCR
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SynteractHCR Appoints Bill Pierce as Chief Information Officer and Richard Paul as Chief Medical Officer and Vice President Medical/Regulatory Affairs
2. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
3. ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
4. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
5. Safe in Commons "The Unfinished Agenda: Addressing the Challenges" Crystalizes Call for Unified Protection Against Needlestick and Sharps Injuries
6. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
10. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
11. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):